The SeeingNano project will create Novel Visualisation Tools for Enhanced Nanotechnology Awareness through a coordinated collaborative approach conducted by leading experts in the relevant fields: the target audiences identified in the proposal will be analysed by the consortium's socio-economic sciences and humanities, who - in collaboration with the consortium's state-of-the-art information visualisation partners - will elaborate and agree on the most appropriate tool to address the respective audiences. The scientific and technical content to be communicate through each tool to the respective audiences will be provided by experts from the nano-phenomena research community in collaboration with experts from the risk-communication and nanotoxicology community, in order to provide the key audiences with an ability to ‘seeing at the nanoscale’, and an understanding and awareness for the breadth of nanotechnologies, and the uncertainties and potential risks connected to them. The resulting tools are flexibly designed for customisation by the nanotechnology stakeholder community, and supported by guidance documents on (a) the socio-economic aspects of awareness-building exercises on nanotechnologies, (b) the science- and technology content and story boards on the nanotechnology-phenomena and their potential risks, and (c) the technical customisation of the tools provided. The It is the ultimate goal of the SeeingNano project to make available a public online SeeingNano exchange with visualisation tools, guidance and content for the enhancement of nanotechnology awareness-building exercises conducted by the nanotechnology stakeholder community. The backbone of this repository is formed by the SeeingNano output: a set of good-communication practices, developed and stress-tested within the project, supported by captivating customisable visualisation tools, to demonstrate the raising of awareness and understanding.

GoNano has as its main objective to improve the responsiveness of research & innovation processes to public values and concerns. The project builds on previous projects in public engagement and new technologies to develop a pilot project in each of the nanotechnology research areas ‘Health’, ‘Energy’ and ‘Food’. The pilot projects will engage citizens with researchers, professional users, civil society organisations, industry, and policy makers in a continuous process of deliberative workshops and online consultations to co-create concrete suggestions for future nanotechnologies. GoNano will build a broad community of ‘change agents’ for integrating an ‘RRI way’ of working on research and innovation, and it will develop and disseminate an RRI business case to align public values, needs and concerns with industry’ for profit ambition. GoNano builds on the basic assumption that several types of knowledge are needed to define sustainability, acceptability, and desirability of nanotechnologies, as well as the belief that online and offline engagement activities must be combined with a creative approach to dissemination and communication to ensure continued interest and engagement in the debate on nanotechnologies future application. GoNano believes that its interactive and open approach to: developing the nanotechnology product suggestion; writing policy recommendation and building an RRI business case; informing and educating about nanotechnology as well as the value of co-creation will build trust and mutual understanding among all the stakeholders, including public and private stakeholders and citizens.

The Genetics Clinic of the Future (GCOF) project aims to ensure that the clinical implementation of genome technologies is relevant and responsive to the needs of all. It offers a stepping stone approach towards the genetics clinic of the future, engaging all stakeholders involved in a process of mutual learning and information exchange. The GCOF project implements key Science with and for Society issues, ensuring that ethical reflection and stakeholder involvement do not occur in parallel, but are effectively integrated in the core of the project. It establishes a robust communication and implementation strategy that integrates the project’s outcomes and recommendations in research and clinical practices and policy processes, outlining opportunities for a more responsive health research and innovation system by: 1. Envisioning the Genetics Clinic of the Future (WP1) 2. Mapping out the concept of data control (WP2) 3. Considering ethical and legal dimensions in the consent framework (WP3) 4. Exploring novel models for use of clinical data in research and vice versa (WP4) 5. Initiating public engagement, mutual learning and dissemination (WP5) 6. Engaging policy makers (WP6) The consortium brings together 12 key partners from 10 countries across Europe who represent the breadth of stakeholders involved in the genetics clinic of the future: genomics research, clinical genetics, bioinformatics, public health, policy making, patient representation, education, commercial genetics and bioinformatics services, social research, communication, responsible innovation and ethics and law. The GCOF project connects to the major EU-initiatives in the field of personalised health and care. The consortium also represents a variety of organisation types, including research organisations, businesses, policy makers, civil society organisations, education establishments and science & society centres.

The main objective of NANORIGO (NANOtechnology RIsk GOvernance) is to develop and implement a transparent, transdisciplinary and science-based Risk Governance Framework (RGF) for managing nanotechnology risks regarding social, environmental and economic benefits. A new risk management approach is formed based on available and new high-quality data and advanced scientific tools developed for industry and regulators decision-making, and on communication with all stakeholders (regulators, industries, politicians, the civil society). The RGF will use a life-cycle perspective and integrate available knowledge on ethical, social, environmental and economic concerns into a user-friendly format that can be easily adapted and transferred into regulation for hazard, exposure and risk assessment and management of nanomaterials. It will consist of: (i) risk management strategies based on reinforced tools for guidance and decision-making developed for risk assessment, (ii) validated methodologies to identify potential hazard and exposure, and (iii) a web-based information and communication platform to facilitate access to good quality data and a clear understanding of risks for all stakeholders, and their valuable feedback. The NANORIGO work plan consists of 8 work packages covering all major risk governance aspects. A self-sustained European Nanotechnology Risk Governance Council (NRGC) will be installed to implement the RGF, embedded in relevant international structures and in close cooperation with the International Risk Governance Center (IRGC). Case studies will demonstrate the sustainability of solutions and their consistent integration into regulatory applications under real conditions. Bringing all stakeholders together under a common umbrella will allow to share and integrate the most appropriate governance tools, frameworks and plans for future science and regulatory research and foster consistency of management approaches in the EU and synergies internationally.